| Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries NA Scott, GD Cipolla, CE Ross, B Dunn, FH Martin, L Simonet, JN Wilcox Circulation 93 (12), 2178-2187, 1996 | 714 | 1996 |
| Stent sheath for local drug delivery NA Scott, SR Hanson, SB King III, LA Harker US Patent 5,383,928, 1995 | 612 | 1995 |
| Device and method for non-occlusive localized drug delivery SR Hanson, NA Scott, SB King III, C Markou US Patent 5,985,307, 1999 | 597 | 1999 |
| Device for local drug delivery and methods for using the same SR Hanson, NA Scott, SB King III, LA Harker US Patent 5,709,874, 1998 | 525 | 1998 |
| Alterations of phasic coronary artery flow velocity humans during percutaneous coronary angioplasty J Segal, MJ Kern, NA Scott, SB King III, JW Doucette, RR Heuser, E Ofili, ... Journal of the American College of Cardiology 20 (2), 276-286, 1992 | 317 | 1992 |
| Perivascular inflammation after balloon angioplasty of porcine coronary arteries E Okamoto, T Couse, H De Leon, J Vinten-Johansen, RB Goodman, ... Circulation 104 (18), 2228-2235, 2001 | 311 | 2001 |
| The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation JN Wilcox, R Waksman, SB King, NA Scott International Journal of Radiation Oncology* Biology* Physics 36 (4), 789-796, 1996 | 276 | 1996 |
| Device for local drug delivery and methods for using the same SR Hanson, NA Scott, SB King III, LA Harker US Patent 5,523,092, 1996 | 268 | 1996 |
| Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment J Segal, N Scott US Patent 7,488,313, 2009 | 259 | 2009 |
| Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries R Waksman, JC Rodriguez, KA Robinson, GD Cipolla, IR Crocker, ... Circulation 96 (6), 1944-1952, 1997 | 254 | 1997 |
| Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment N Scott, J Segal US Patent 7,292,885, 2007 | 247 | 2007 |
| Polymer coated device for electrically medicated drug delivery N Scott, J Segal, LB Shih, TL Burkoth US Patent 7,517,342, 2009 | 224 | 2009 |
| Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment J Segal, N Scott US Patent 7,488,314, 2009 | 224 | 2009 |
| Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury NA Scott Advanced drug delivery reviews 58 (3), 358-376, 2006 | 210 | 2006 |
| Potential role of the adventitia in arteritis and atherosclerosis JN Wilcox, NA Scott International Journal of Cardiology 54, S21-S35, 1996 | 195 | 1996 |
| Elevation of plasma neuropeptide Y levels in congestive heart failure AS Maisel, NA Scott, HJ Motulsky, MC Michel, JH Boublik, JE Rivier, ... The American journal of medicine 86 (1), 43-48, 1989 | 142 | 1989 |
| Overview of therapies for prevention of restenosis after coronary interventions SM Garas, P Huber, NA Scott Pharmacology & Therapeutics 92 (2-3), 165-178, 2001 | 129 | 2001 |
| Endovascular support device and method of use R Waksman, SB King III, NA Scott US Patent 6,355,055, 2002 | 100 | 2002 |
| High concentration medicament and polymer coated device for passive diffusional medicament delivery N Scott, T Burkoth, S Harris US Patent App. 11/027,336, 2005 | 95 | 2005 |
| Tyrosine prevents behavioral and neurochemical correlates of an acute stress in rats DK Reinstein, H Lehnert, NA Scott, RJ Wurtman Life sciences 34 (23), 2225-2231, 1984 | 93 | 1984 |